Nicola Marino looks at a new paper proposing an

Aman Clinics is bringing Cenegenics’ physician

New foundation model and an expanded GSK partner

Decode Age, registered as Centenarians Life Scien

UnitedHealth Group is providing a $4 million comm

HAYA Therapeutics has received Fast Track designa

Ossium Health has been named to Forbes’ 2026 Ne

Genflow Biosciences reported progress in its SLAB

Insilico announced that ISM6331, its AI‑designe

Niagen Bioscience published a peer-reviewed analy

United Therapeutics reported that The Lancet has

New international consortium argues healthy agin

All patients have reached the highest planned do

InsideTracker’s Jon Michaeli explains why well

ProMIS Neurosciences reported positive blinded si

Longevity AI and researchers from Meir Medical Ce

Aman Clinics, a subsidiary of Aman Hospital and a

Rules for SB 535 are now in place, clearing the

The longevity clinic network is adding Californi

Completion of enrollment brings the first clinic

Insilico Medicine announced that first-in-human P

Indiana University and Pharmatrophix presented a

Humacyte announced that the U.S.

Six of seven compounds clear a reconstituted com

New six-month data strengthen the case for a one

Breakthroughs in longevity research are accelera

Serotonin Centers opened a new location in Del Ma

NADclinic Group and the Geneva College of Longevi

AnHorn Medicines on 23 July 2026 reported that th

Serina Therapeutics will participate in the BTIG

Collaboration adds multiple potential obesity dr

New data suggest LM11A-31 may help preserve the

HCW Biologics has requested a Type B pre-Investig

Insilico Medicine nominated ISM9528 as a Preclini

Serina Therapeutics announced that it has complet

London event expands as founders, investors and

As personalized nutrition grows, experts argue t

Lausanne-based Vandria presented multiple ascendi

Winona, a physician-led telehealth company focuse

Immorta Bio published a peer-reviewed Perspective

i-Lumen Scientific, a clinical-stage medical tech

i-Lumen Scientific, a clinical-stage medical tech

California-based Frontier Bio was named a Phase 1

D&D Pharmatech reported publication in Lancet Gas

NeuroSense intends to proceed with a New Drug Sub

The Emerald update redesigns the app around acti

Federal court ruling highlights growing pressure

Federal court ruling highlights growing pressure

Wellthspan Advisory’s Nadine Esposito explains

New UAE-backed venture bets future of longevity